Functional Visual Acuity Assessment of Severe Atopic Keratoconjunctivitis

被引:7
作者
Ibrahim, Osama M. A. [1 ]
Dogru, Murat [1 ,2 ]
Kaido, Minako [1 ]
Kojima, Takashi [1 ]
Fujishima, Hiroshi [3 ]
Tsubota, Kazuo [1 ]
机构
[1] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo 1608582, Japan
[2] Tokyo Dent Coll, Dept Ophthalmol, Ichikawa, Japan
[3] Tsurumi Univ, Dept Ophthalmol, Sch Dent Med, Yokohama, Kanagawa, Japan
关键词
atopic keratoconjunctivitis; visual acuity; eye drop treatment; TOPICAL CYCLOSPORINE-A; STEVENS-JOHNSON-SYNDROME; ALLERGIC CONJUNCTIVITIS; DRY EYE; OCULAR COMPLICATIONS; CONTROLLED-TRIAL; DERMATITIS; EFFICACY;
D O I
10.1097/ICO.0000000000000245
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose:To evaluate changes in functional visual acuity (FVA) measurements before and after treatment with 0.1% cyclosporine ophthalmic solution for 3 months in patients with severe atopic keratoconjunctivitis (AKC).Methods:Pairs of eyes were analyzed from 3 boys (mean age 9 3.6 years) who complained of having severe AKC and were recruited for the study. Conventional Landolt visual acuity, FVA, and visual maintenance ratio (VMR) measurements were conducted before and after 3 months of 0.1% cyclosporine eye drop treatment. Tear film lipid layer interferometry, tear film break-up time, fluorescein and rose bengal vital stainings, and the Schirmer test were also performed before and after treatment.Results:Eye drop treatment was associated not only with improvement of tear function and ocular surface status but also with better quality of visual function. The mean logarithm of the minimum angle of resolution FVA and Landolt visual acuity values improved from 0.45 +/- 0.26 and 0.13 +/- 0.17 before treatment to 0.16 +/- 0.03 and -0.06 +/- 0.05 after treatment, respectively. Similarly, the mean VMR values were markedly improved from 0.88 +/- 0.06 to 0.95 +/- 0.03 after treatment.Conclusions:FVA and VMR are promising parameters in the assessment of dynamic visual acuity changes in AKC-affected patients and evaluation of treatment outcome.
引用
收藏
页码:S13 / S18
页数:6
相关论文
共 27 条
  • [1] BRAUDE L S, 1984, International Ophthalmology Clinics, V24, P145, DOI 10.1097/00004397-198402420-00013
  • [2] Çetinkaya A, 2004, CORNEA, V23, P194
  • [3] CYCLOSPORINE - A NEW IMMUNOSUPPRESSIVE AGENT FOR ORGAN-TRANSPLANTATION
    COHEN, DJ
    LOERTSCHER, R
    RUBIN, MF
    TILNEY, NL
    CARPENTER, CB
    STROM, TB
    [J]. ANNALS OF INTERNAL MEDICINE, 1984, 101 (05) : 667 - 682
  • [4] Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis
    Daniell, M
    Constantinou, M
    Vu, HT
    Taylor, HR
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2006, 90 (04) : 461 - 464
  • [5] EASTY D, 1975, T OPHTHAL SOC UK, V95, P267
  • [6] A Large Prospective Observational Study of Novel Cyclosporine 0.1% Aqueous Ophthalmic Solution in the Treatment of Severe Allergic Conjunctivitis
    Ebihara, Nobuyuki
    Ohashi, Yuichi
    Uchio, Eiichi
    Okamoto, Shigeki
    Kumagai, Naoki
    Shoji, Jun
    Takamura, Etsuko
    Nakagawa, Yayoi
    Nanba, Kenichi
    Fukushima, Atsuki
    Fujishima, Hiroshi
    [J]. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2009, 25 (04) : 365 - 371
  • [7] FOSTER CS, 1990, OPHTHALMOLOGY, V97, P992
  • [8] Retrospective survey of a link between cat and dog antigens and allergic conjunctivitis
    Fujishima, H
    Shimazaki, J
    Yang, HY
    Toda, I
    Tsubota, K
    [J]. OPHTHALMOLOGICA, 1996, 210 (02) : 115 - 118
  • [9] GARRITY JA, 1984, CAN J OPHTHALMOL, V19, P21
  • [10] Impaired functional visual acuity of dry eye patients
    Goto, E
    Yagi, Y
    Matsumoto, Y
    Tsubota, K
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2002, 133 (02) : 181 - 186